|
- 积分
- 1
- 威望
- 1
- 包包
- 292
|
When Nature broke the news in December 2011 that Novartis' L4 S `/ Z' j% |0 ~
was to close its brain research facility in Basel, Switzerland,
; A9 }3 P9 f) m/ N, b) v3 c% b! ]the story noted that this move closely followed similar cuts2 f0 s$ r5 I7 q
by rival pharmaceutical firms. As a report from the European College" K1 l" p8 l/ w9 C
of Neuropsychopharmacology3 O# Z3 O8 ^4 Z; L
had warned a few months earlier, the _( G- c8 V( D2 h) G+ }) M& s& j
abandonment of research into new psychiatric drugs by AstraZeneca,1 x- E% h, X0 e6 S& i4 R: u0 T
GlaxoSmithKline
" D: w6 l) z/ Mand others meant that “withdrawal of research1 [4 z5 ?5 O; v9 r
resources is a withdrawal of hope for patients and their families”.
% m( W+ Z* | N2 G/ t/ F- J6 l2 R4 O4 h+ L2 q6 z" \% |
( m8 S* E3 _7 G+ N
回复有免费下载链接
1 u9 b! w& H9 \
: s% i: G; D8 o+ Q |
-
总评分: 包包 + 20
查看全部评分
|
发表于 2013-10-12 08:22
发表于 2013-10-12 08:44
